Please Wait
Applying Filters...
menu
    • menu
    Mix Gif-PSE
    News
    Africa CDC and Aspen Pharmacare aim to Boost Vaccine Output

    13 May 2026

    // PRESS RELEASE

    Isomorphic Labs Secures $2.1B To Expand AI Drug Design Engine

    13 May 2026

    // PR NEWSWIRE

    Trump Confirms Makary is out at FDA

    13 May 2026

    // RAPS

    DATA COMPILATION
    #PharmaFlow

    #1

    Contact Supplier

    Website

    CPhI China

    Attending

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.pharmacompass.com/video-supplier-spotlight/apisyn/corporate-video
    Menu

    ApiSyn

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    Key Products KEY PRODUCTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1Apisyn Healthcare Pvt. Ltd

    PharmaCompass
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    01

    Inspected

    RoW
    CPhI China
    Attending

    ApiSyn

    Inspection : Survey No. - 325, Village Zekda, Tal. - Bavia, Dist.-Ahmedabad - 382230, Gujarat, India

    About the Company : Operational since 2024, ApiSyn Healthcare Pvt. Ltd. is a rapidly growing cGMP manufacturer and CDMO ...

    Operational since 2024, ApiSyn Healthcare Pvt. Ltd. is a rapidly growing cGMP manufacturer and CDMO specializing in APIs, intermediates, peptides, and amino acids across two dedicated manufacturing facilities. Accredited to ISO 9001:2015 and WHO cGMP, with US DMF and CEP filings, ApiSyn delivers regulatory-compliant, high-quality products supported by robust documentation, strong R&D capabilities, and advanced infrastructure. Note: Products will not be supplied where this conflicts with existing patents. Products under patent are offered for R&D purposes only, with final responsibility resting with the buyer.

    Country : India

    Company Banner

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Contact Apisyn and get a quotation

    Apisyn is a supplier offers 27 products (APIs, Excipients or Intermediates).

    Find Apixaban bulk with DMF offered by Apisyn

    Find Linezolid bulk with DMF offered by Apisyn

    Find Alogliptin Benzoate bulk offered by Apisyn

    Find Avatrombopag Maleate bulk offered by Apisyn

    Find Dapagliflozin bulk offered by Apisyn

    Find Dapagliflozin Propanediol Monohydrate bulk offered by Apisyn

    Find Desmopressin Acetate bulk offered by Apisyn

    Find Elafibranor bulk offered by Apisyn

    Find Empagliflozin bulk offered by Apisyn

    Find Gepirone bulk offered by Apisyn

    Find Ivacaftor bulk offered by Apisyn

    Find Lofexidine bulk offered by Apisyn

    Find Macitentan bulk offered by Apisyn

    Find Mavacamten bulk offered by Apisyn

    Find Memantine Hydrochloride bulk offered by Apisyn

    Find Methimazole bulk offered by Apisyn

    Find Octreotide Acetate bulk offered by Apisyn

    Find Palovarotene bulk offered by Apisyn

    Find Patiromer Sorbitex Calcium bulk offered by Apisyn

    Find Pitolisant Hydrochloride bulk offered by Apisyn

    Find Remibrutinib bulk offered by Apisyn

    Find Rivaroxaban bulk offered by Apisyn

    Find Seladelpar Lysine bulk offered by Apisyn

    Find Semaglutide bulk offered by Apisyn

    Find Solifenacin Succinate bulk offered by Apisyn

    Find Sotalol Hydrochloride bulk offered by Apisyn

    Find Vildagliptin bulk offered by Apisyn

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.